概括
癌细胞中的激素受体可能充当瘤基因,促进瘤生长和存活,特别是在雌激素等激素存在时. 这挑战了它们作为差异化标记物的作用,并提出了一个新的治疗点.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 激素可能会调节癌细胞的增殖,类似于来自瘤基因的生长因子.
- 激素受体基因可以作为细胞瘤基因发挥作用.
- 雌激素受体在正常的成年乳腺细胞中稀缺,但在乳腺癌中存在.
研究的目的:
- 假设癌细胞中的激素受体作为瘤基因起作用.
- 重新评估雌激素受体在乳腺癌中的作用.
- 探索对激素对抗剂疗法的影响.
主要方法:
- 假定一种荷尔蒙受体作为瘤基因的模型.
- 在癌症生长中对雌激素,益生菌素和索马托米丁的作用的分析.
- 考虑激素对抗机制的考虑.
主要成果:
- 乳腺癌中的雌激素受体可能会赋予生存优势,而不是表明分化.
- 益生素和索马托米丁也可能作为生长因子.
- 由于生长因子和受体,癌细胞可能会不朽化和不分化.
结论:
- 从不响应组织的癌症中,重新表达的受体基因是常见的.
- 癌细胞中的激素受体应该被视为瘤基因和生存因素.
- 这种观点可能有助于使用像塔莫西芬这样的激素抗剂.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...


